RhumbLine Advisers’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
228,949
+2,300
| +1% | +$11.6K | ﹤0.01% | 2171 |
|
|
2025
Q1 | $1.47M | Sell |
226,649
-10,032
| -4% | -$65K | ﹤0.01% | 1972 |
|
|
2024
Q4 | $1.74M | Buy |
236,681
+1,288
| +0.5% | +$9.45K | ﹤0.01% | 1964 |
|
|
2024
Q3 | $1.76M | Sell |
235,393
-3,111
| -1% | -$23.3K | ﹤0.01% | 1979 |
|
|
2024
Q2 | $2.12M | Buy |
238,504
+9,817
| +4% | +$87.4K | ﹤0.01% | 1852 |
|
|
2024
Q1 | $2.32M | Sell |
228,687
-46,771
| -17% | -$474K | ﹤0.01% | 1833 |
|
|
2023
Q4 | $2.77M | Buy |
275,458
+13,471
| +5% | +$136K | ﹤0.01% | 1741 |
|
|
2023
Q3 | $2.45M | Buy |
261,987
+14,374
| +6% | +$135K | ﹤0.01% | 1758 |
|
|
2023
Q2 | $6.07M | Buy |
247,613
+12,225
| +5% | +$300K | 0.01% | 1267 |
|
|
2023
Q1 | $5.48M | Buy |
235,388
+14,666
| +7% | +$341K | 0.01% | 1261 |
|
|
2022
Q4 | $5.59M | Sell |
220,722
-1,645
| -0.7% | -$41.6K | 0.01% | 1220 |
|
|
2022
Q3 | $4.29M | Buy |
222,367
+7,561
| +4% | +$146K | 0.01% | 1329 |
|
|
2022
Q2 | $5.47M | Buy |
214,806
+150,037
| +232% | +$3.82M | 0.01% | 1194 |
|
|
2022
Q1 | $1.67M | Buy |
64,769
+915
| +1% | +$23.5K | ﹤0.01% | 1906 |
|
|
2021
Q4 | $2.67M | Sell |
63,854
-480
| -0.7% | -$20.1K | ﹤0.01% | 1727 |
|
|
2021
Q3 | $2.8M | Buy |
64,334
+1,383
| +2% | +$60.2K | ﹤0.01% | 1702 |
|
|
2021
Q2 | $2.98M | Buy |
62,951
+2,566
| +4% | +$121K | ﹤0.01% | 1736 |
|
|
2021
Q1 | $3.1M | Sell |
60,385
-5,050
| -8% | -$259K | ﹤0.01% | 1676 |
|
|
2020
Q4 | $1.75M | Buy |
65,435
+4,307
| +7% | +$115K | ﹤0.01% | 1914 |
|
|
2020
Q3 | $2.1M | Sell |
61,128
-7,679
| -11% | -$264K | ﹤0.01% | 1657 |
|
|
2020
Q2 | $2.82M | Buy |
68,807
+58,253
| +552% | +$2.39M | ﹤0.01% | 1539 |
|
|
2020
Q1 | $362K | Buy |
+10,554
| New | +$362K | ﹤0.01% | 2314 |
|